Pulse Biosciences Inc (PLSE)
NASDAQ
49.98
+0.89 (+1.81%)
Closed
Oct 8, 2026
Day's Range
47.3150.32
52 wk Range
12.5658.90
Financial Statements - PLSE - Pulse Biosciences Inc
Revenue
350.00K
Net Income
-72.78M▼ 35.8%Net Margin -20794.6%
EBITDA
-75.86M▼ 37.7%
Free Cash Flow
-54.45M▼ 49.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 350K | 0 | 0 | 700K | 1.41M | 0 |
| Cost of Goods | 539K | - | 0 | 11.94M | 1.96M | 0 |
| Gross Profit | -189K | - | 0 | -11.24M | -550K | 0 |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -76.93M | -56.25M | -43.57M | -58.05M | -63.01M | -49.96M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -52K | - | - | - | - | - |
| Pre Tax Income | -72.78M | -53.58M | -42.21M | -58.50M | -63.66M | -49.85M |
| Income Tax | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | -72.78M | -53.58M | -42.21M | -58.50M | -63.66M | -49.85M |
| EPS Basic | -1.08 | -0.92 | -0.865329 | -1.691325 | -2.241989 | -2.104323 |
| EPS Diluted | -1.08 | -0.92 | -0.865329 | -1.691325 | -2.241989 | -2.104323 |
| Basic Shares Outstanding | 67.39M | 58.39M | 48.85M | 34.51M | 28.43M | 23.64M |
| Diluted Shares Outstanding | 67.39M | 58.39M | 48.85M | 34.51M | 28.43M | 23.64M |
| Ebit | -76.93M | -56.25M | -43.57M | -58.05M | -63.01M | -49.96M |
| Ebitda | -75.86M | -55.07M | -42.36M | -56.70M | -61.86M | -48.87M |
| Net Income Continuous Operations | -72.78M | -53.58M | -42.21M | -58.50M | -63.66M | -49.85M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
